Prediction of the results of rheumatoid arthritis therapy with leflunomide
- 作者: Saritkhala V.1, Yagoda A.1, Koroy P.1
-
隶属关系:
- Stavropol State Medical University
- 期: 卷 30, 编号 10 (2019)
- 页面: 36-39
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114080
- DOI: https://doi.org/10.29296/25877305-2019-10-07
- ID: 114080
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The investigation of the plasma level of adhesion molecules in patients with rheumatoid arthritis revealed that the values of a number of adhesins became normal during leflunomide therapy, especially if effective. The favorable response to treatment was associated with the high baseline blood levels of intercellular adhesion molecule-1, which is the basis for using them as predictors of successful therapy.
全文:
作者简介
V. Saritkhala
Stavropol State Medical University
Email: paule75@yandex.ru
A. Yagoda
Stavropol State Medical University
Email: paule75@yandex.ru
P. Koroy
Stavropol State Medical University
Email: paule75@yandex.ru
参考
- Каратеев Д.Е., Орлова Е.В. Лефлуномид при раннем ревматоидном артрите: включение в стратегию лечения и перспективы // Мед. совет. - 2017; 11: 91-6
- Smolen J., Landewe R., Bijlsma J. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update // Ann. Rheum. Dis. - 2017; 76 (6): 960-77. doi: 10.1136/annrheumdis-2016-210715.
- Zeb S., Wazir N., Waqas M. et al. Comparison of short-term efficacy of leflunomide and methotrexate in active rheumatoid arthritis // J. Postgrad. Med. Inst. - 2016; 30 (2): 177-80.
- Golicki D., Niewada M., Lis J. et al. Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials // Pol. Arch. Wewn. - 2012; 122 (1-2): 22-32. doi: 10.20452/pamw.1131.
- Mathur R., Singh H., Arya S. et al. Comparative evaluation of efficacy of leflunomide versus combination of methotrexate and hydroxychloroquine in patients of rheumatoid arthritis - аn Indian experience // Indian J. Rheumatol. -2016; 11 (2): 86-90. doi: 10.1016/j.injr.2016.03.002.
- Benucci M., Saviola G., Baiardi P. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis // Int. J. Immunopathol. Pharmacol. - 2011; 1: 269-74. doi: 10.1177/039463201102400136.
- Hodkinson B., Magomero R., Tikly M. Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach // Ther. Adv. Musculoskelet. Dis. - 2016; 8 (5): 172-9. doi: 10.1177/1759720X16664324.
- Ягода А.В., Саритхала В.Д., Корой П.В. Анемия при ревматоидном артрите: взаимосвязь с гепсидином и молекулами адгезии // Мед. вестн. Северного Кавказа. - 2018; 13 (2): 338-42
- Klimek E., Skalska A., Kwasny-Krochin B. et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration // Mediators Inflamm. - 2014; 2014: 681635. doi: 10.1155/2014/681635.
- Koroy P., Sarithala V., Yagoda A. Soluble molecules of immunoglobulins superfamily in rheumatoid arthritis // Medical news of North Caucasus. - 2017; 12 (3): 256-60. DOI: org/10.14300/mnnc.2017.12092.
- Sarithala V., Koroy P., Yagoda A. Variations in levels of intercellular adhesion molecule-1 with disease course, in rheumatoid arthritis patients // J. Clin. Diagnostic Res. - 2018; 12 (9): 18-21. doi: 10.7860/JCDR/2018/35302.12044.
- Sodergren A., Karp K., Boman K. et al. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness // Arthritis Res. Ther. - 2010; 12 (4): R158. doi: 10.1186/ar3116.
- Klimiuk P., Sierakowski S., Domyslawska I. et al. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis // Scand. J. Rheumatol. - 2009; 38 (6): 439-44. doi: 10.3109/03009740903079321.
- Koroy P., Sarithala V., Yagoda A. Biological therapy of rheumatoid arthritis: is real prediction of efficacy? // Medical News of North Caucasus. - 2018; 13 (3): 463-7. doi: 10.14300/mnnc.2018.13078.
- Klimiuk P., Fiedorczyk M., Sierakowski S. et al. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis // Scand. J. Rheumatol. - 2007; 36 (5): 345-50. doi: 10.1080/03009740701406460.
- Oranskiy S., Yeliseyeva L. Serum concentration of immune, endocrine and endothelial biomarkers in patients with rheumatoid arthritis associated with different variants of metabolic status treated with infliximab // Medical news of North Caucasus. - 2016; 11 (2): 139-42. doi: 10.14300/mnnc.2016.11019.
- Shu Q., Amin M., Ruth J. et al. Suppression of endothelial cell activity by inhibition of TNF alpha // Arthritis Res. Ther. - 2012; 14 (2): R88. doi: 10.1186/ar3812.
- Комарова Е.Б., Ребров Б.А., Князева А.К. Ингибитор ангиотензинпревращающего фермента в комплексном лечении ревматоидного артрита // Современная ревматология. - 2017; 11 (3): 72-6
- Canhao H., Rodrigues A., Mourao A. et al. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis // Rheumatology. - 2012; 51 (11): 2020-6. doi: 10.1093/rheumatology/ kes184.
- Tanaka H., Kanazawa M., Kawakami T. Efficacy and safety of tocilizumab therapy in rheumatoid arthritis: prevalence and predictive factors of sustained remission // Ann. Rheum. Dis. - 2013; 72: А453. doi: 10.1136/annrheumdis-2013-eular.1363.
补充文件
